PTPN6 and chronic myelogenous leukemia, BCR-ABL1 positive: Epigenetic processes were shown to regulate SHP1 mRNA expression in CML and, when these data were compared to healthy individuals, SHP1 expression levels were found to be downregulated at diagnosis and further reduced during disease progression phases (AP and BP) [136,137].